相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial
Kieran F. Docherty et al.
EUROPEAN JOURNAL OF HEART FAILURE (2023)
Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study
Andrew Abboud et al.
JOURNAL OF CARDIAC FAILURE (2022)
Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan
Peder L. Myhre et al.
JACC-HEART FAILURE (2022)
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
Douglas L. Mann et al.
JAMA CARDIOLOGY (2022)
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa Gonzalez et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Paul A. Heidenreich et al.
JOURNAL OF CARDIAC FAILURE (2022)
Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure
Kazutaka Nogi et al.
ESC HEART FAILURE (2022)
Possible Association Between Body Temperature and B-Type Natriuretic Peptide in Patients With Cardiovascular Diseases
Ryeonshi Kang et al.
JOURNAL OF CARDIAC FAILURE (2021)
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Hiroyuki Tsutsui et al.
CIRCULATION JOURNAL (2021)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial
Jawad H. Butt et al.
CIRCULATION-HEART FAILURE (2021)
Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction
Kazushi Sakane et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Katherine N. Bachmann et al.
JACC-HEART FAILURE (2021)
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The Universal Definition of Heart Failure: Perspectives from Diverse Stakeholders
Robert J. Mentz et al.
JOURNAL OF CARDIAC FAILURE (2021)
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Election Fraction
Sean P. Murphy et al.
JACC-HEART FAILURE (2021)
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
Sean P. Murphy et al.
CIRCULATION-HEART FAILURE (2021)
The struggle towards a Universal Definition of Heart failure-how to proceed?
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
Jr James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo
Haruka Kimura et al.
SCIENTIFIC REPORTS (2021)
BNP-Response to Acute Heart Failure Treatment Identifies High-Risk Population
Achint N. Patel et al.
HEART LUNG AND CIRCULATION (2020)
Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure
Masataka Kamiya et al.
HEART AND VESSELS (2020)
Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure
Gema Minana et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)
Natriuretic Peptides as Inclusion Criteria in Clinical Trials A JACC: Heart Failure Position Paper
Nasrien E. Ibrahim et al.
JACC-HEART FAILURE (2020)
Should Enrichment With Natriuretic Peptide Levels Be Mandatory in Global Clinical Trials?
Adriaan A. Voors
JACC-HEART FAILURE (2020)
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial Insights From COMMANDER HF
Jonathan W. Cunningham et al.
JACC-HEART FAILURE (2020)
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction
Jonathan W. Cunningham et al.
JACC-HEART FAILURE (2020)
Cardiac natriuretic peptides
Jens P. Goetze et al.
NATURE REVIEWS CARDIOLOGY (2020)
Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan
James L. Januzzi et al.
CIRCULATION-HEART FAILURE (2020)
CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation
Meritxell Soler et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
Justin A. Ezekowitz et al.
JACC-HEART FAILURE (2020)
Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fraction
Benjamin S. Wessler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan The PARADIGM-HF Trial
Peder Langeland Myhre et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry
Ovidiu Chioncel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Christian Mueller et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure - Digest Version -
Hiroyuki Tsutsui et al.
CIRCULATION JOURNAL (2019)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effects of Serelaxin in Patients with Acute Heart Failure
Marco Metra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database
Toshiyuki Nagai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF
Melissa A. Daubert et al.
JACC-HEART FAILURE (2019)
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
Jorge Rubio-Gracia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department The ICON-RELOADED Study
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Muthiah Vaduganathan et al.
JACC-HEART FAILURE (2018)
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)
Susan Stienen et al.
CIRCULATION (2018)
Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction - Baseline Characteristics and Treatment of PARALLEL-HF Trial
Hiroyuki Tsutsui et al.
CIRCULATION JOURNAL (2018)
Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points: From the ASCEND-HF Trial
Stephen J. Greene et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research
Gad Cotter et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
G. Michael Felker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
M. Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The bumpy road to drug development for acute heart failure
Carine E. Hamo et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2016)
Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction
Hesham R. Omar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Natriuretic peptide-guided management in heart failure
Ovidiu Chioncel et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A Test in Context: Neprilysin Function, Inhibition, and Biomarker
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Predictors of Six-Month Mortality in BNP-Matched Acute Heart Failure Patients
Patricia Lourenco et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Effects of ivabradine therapy on heart failure biomarkers
Serkan Ordu et al.
CARDIOLOGY JOURNAL (2015)
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Susan Stienen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Atrial Natriuretic Peptide Locally Counteracts the Deleterious Effects of Cardiomyocyte Mineralocorticoid Receptor Activation
Hitoshi Nakagawa et al.
CIRCULATION-HEART FAILURE (2014)
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score
Khibar Salah et al.
HEART (2014)
Learning from recent trials and shaping the future of acute heart failure trials
Robert J. Mentz et al.
AMERICAN HEART JOURNAL (2013)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Sarah Mangiafico et al.
EUROPEAN HEART JOURNAL (2013)
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN HEART JOURNAL (2013)
B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Dirk J. van Veldhuisen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes
Marica Bordicchia et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims
Robb D. Kociol et al.
CIRCULATION-HEART FAILURE (2011)
Natriuretic peptide metabolism, clearance and degradation
Lincoln R. Potter
FEBS JOURNAL (2011)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
C. M. O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care†
Per Hildebrandt et al.
EUROPEAN HEART JOURNAL (2010)
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
Adrian F. Hernandez et al.
AMERICAN HEART JOURNAL (2009)
Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction
Konstantinos P. Letsas et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart
Takeshi Tokudome et al.
CIRCULATION (2008)
Effects of Carperitide on the Long-Term Prognosis of Patients With Acute Decompensated Chronic Heart Failure-The PROTECT Multicenter Randomized Controlled Study-
Noritake Hata et al.
CIRCULATION JOURNAL (2008)
Multicenter Prospective Investigation on Efficacy and Safety of Carperitide as a First-Line Drug for Acute Heart Failure Syndrome With Preserved Blood Pressure-COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study
Fumihiro Nomura et al.
CIRCULATION JOURNAL (2008)
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness trial)
Monica R. Shah et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure
Jose Paulo Araujo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure
Roland R. J. van Kimmenade et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
JL Januzzi et al.
EUROPEAN HEART JOURNAL (2006)
NT-ProBNP in acute heart failure: Correlation with invasively measured hemodynamic parameters during recompensation
F Knebel et al.
JOURNAL OF CARDIAC FAILURE (2005)
Short-term risk of death after treatment with nesiritide for decompensated heart failure - A pooled analysis of randomized controlled trials
JD Sackner-Bernstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure
JD Sackner-Bernstein et al.
CIRCULATION (2005)
Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase
KK Ma et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
A Gackowski et al.
EUROPEAN HEART JOURNAL (2004)
Primary results of the rapid emergency department heart failure outpatient trial (REDHOT)
A Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
P Bettencourt et al.
CIRCULATION (2004)
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand et al.
CIRCULATION (2003)
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
R Kazanegra et al.
JOURNAL OF CARDIAC FAILURE (2001)
分享论文
